Overview

Cannabidiol and Management of Endometriosis Pain

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) in patients with endometriosis. It is believed that CBD will improve both pain and quality of life. The study will last a total of 12 weeks and involve several onsite visits in addition to daily pain assessments.
Phase:
Phase 3
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Treatments:
Cannabidiol
Epidiolex
Norethindrone
Norethindrone Acetate